Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase Mu 2 (GSTM2) is an enzyme of the mu class within the glutathione S-transferase superfamily, primarily found in the cytosol. It catalyzes the conjugation of reduced glutathione to a broad range of endogenous and exogenous hydrophobic electrophiles, thereby facilitating detoxification, scavenging reactive species, and protecting cells from oxidative stress. GSTM2 also plays specialized roles in lipid metabolism regulation and inhibits cell death signaling by binding to ASK1. The gene is highly polymorphic, which contributes to individual variability in susceptibility to carcinogens, drug toxicity, and metabolic diseases such as hepatic steatosis[1][2][4][6].
Conjugation of reduced glutathione to hydrophobic electrophiles, increasing solubility and facilitating excretion; Protection from oxidative stress by scavenging reactive oxygen species; Inhibition of stress kinases (ASK1, JNK), impacting cell survival signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase Mu 2 (GSTM2).